NEWS ON BIOANALYSIS Podcasts
Your Bioanalysis News Update: Discover the chimera biotec Podcast
In the dynamic world of bioanalysis, staying up-to-date is crucial. But the flood of information makes it difficult to keep track of everything. With the Podcast News from chimera biotec, we deliver the most important news and in-depth insights directly to your ears—curated by experts, for experts.
Why this Podcast?
- Expert Knowledge on Demand: We are chimera biotec. Our team of bioanalysis specialists shares their insider knowledge and analyzes the industry’s most important trends and studies.
- Time-Saving Education: Listen to the latest developments in bioanalysis whenever and wherever it suits you—in the lab, on your commute, or in your free time.
- Compact Insights: We filter out what’s essential so you can focus on what truly matters.
Listen and Subscribe Now:
The chimera biotec podcast is more than just a summary of headlines. Each episode is a carefully curated journey into the current developments that are crucial for your daily work. We dive deep into:
-
Innovative Analytical Methods: From mass spectrometry to immunoassays and next-generation sequencing, we highlight the latest technologies and their practical applications.
-
Best Practices and Case Studies: Learn from the best. In our episodes, leading experts from industry and academia share their experiences, provide valuable tips, and discuss real-world success stories.
-
Regulatory Updates: We keep you informed about constantly changing regulations and guidelines to ensure your research and development remain compliant.
Meet Our Experts
Behind the microphone is the heart of chimera biotec: a team of passionate bioanalysts who don’t just talk about science—they live it every day. Their well-founded analyses and enthusiasm for the field make every podcast an authentic and inspiring listening experience.
Ready for Your Next Update?
Don’t miss an episode. Subscribe to our podcast on your preferred platform and become part of the community shaping the future of bioanalysis.
Find Podcasts
Benefit from more than 20 years of experience in PK assay development
-
Sensitivity meets assay range: One of Chimera’s major expertise is ultra-sensitive PK study support. Combining a broad quantitative range with an excellent sensitivity, we offer unmatched biologics PK support using a single assay format. From high dosing in TOX studies through extremly low dosing in dose escalation in the later clinical stage- Chimera provides regulated PK sample testing using validated methods, based on the same assay format adapted to the intended range of application. This eliminates the need to run several assays to pair sensitivity and dynamic assay range.
- PK profile: Chimera’s capability to measure low concentrations of a given drug, we are able to provide a complete PK profile even for initial doses and thus shorten Phase I trials. Our high-quality data meets your regulatory requirements and can be decisive to evaluate drug distribution and clearance behaviors.
Ask a PK PD Assay Development Specialist
PK PA assay testing in rare matrices
Chimera’s long-running experience in diverse and rare matrices helps to understand the pharmacokinetic profile of your drug compound in virtually any matrix:
- Serum/ plasma
- Cerebrospinal fluid (CSF)
- Cell culture medium
- Bronchoalveolar lavage fluid (BALF)
- Tissue extracts and lysates
- Mouse tail vein
- Tears
- Saliva
- Synovial fluid
- And many more
PK PD assay testing service – Step by step –
1. Click on the button below and tell our science team what your challenge is.
2. We will arrange a meeting with you under CDA conditions.
3. You will receive an offer from us that meets all your requirements.
We look forward to your challenge.
Start your PK Assay Project Now
Selection of PK studies supported by Chimera:
- Cooperation Between Systemic and Mucosal Antibodies Induced by Virosomal Vaccines Targeting HIV-1 Env: Protection of Indian Rhesus Macaques Against Low-Dose Intravaginal SHIV Challenges.
Access here
- Randomized phase I trials of the safety/tolerability of anti-LINGO-1 monoclonal antibody BIIB033
Access here
- Phase I trial of intravenous aviscumine (rViscumin) in patients with solid tumors: a study of the European Organization for Research and Treatment of Cancer New Drug Development Group
Access here
Unmatched sensitivity in PK PD Assay Service
PK PD assay services: Case studies
LBA bioanalytical PK support for biologics: The need for sensitivity combined with a broad assay range:
Request the poster including three case studies, that show ultra-sensitive therapeutic antibody quantification in biological matrix.
Ask our Scientist Team
Questions about our PK PD Assay Services ?
Contact us
Discover the benefits of our first-class solutions! Press the contact button now to arrange a free meeting with one of our scientists. Take advantage of this unique opportunity to clarify your questions and receive individual advice for your projects. Let our expertise convince you and take your research to the next level!
Call us now
Find out how Chimera Biotec can advance your research!
Empowering your scientific discoveries.
